US6395959B1
(en)
*
|
1992-05-05 |
2002-05-28 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I SceI and the use thereof
|
US5792632A
(en)
*
|
1992-05-05 |
1998-08-11 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
|
US20020136708A1
(en)
|
1993-06-24 |
2002-09-26 |
Graham Frank L. |
System for production of helper dependent adenovirus vectors based on use of endonucleases
|
AU2004202860B2
(en)
*
|
1999-02-03 |
2008-01-24 |
Institut Pasteur |
Gene repair involving in vivo excision of targeting DNA
|
EP1147209A2
(de)
*
|
1999-02-03 |
2001-10-24 |
The Children's Medical Center Corporation |
Genreparatur durch induzierte doppelsträngige dna-schneidung an einer chromosomalen targetstelle
|
AU2982300A
(en)
*
|
1999-02-03 |
2000-08-25 |
Children's Medical Center Corporation |
Gene repair involving (in vivo) excision of targeting dna
|
AU769735B2
(en)
*
|
1999-02-18 |
2004-02-05 |
Advec, Inc. |
A system for production of helper dependent adenovirus vectors based on use of endonucleases
|
US6890726B1
(en)
|
1999-04-06 |
2005-05-10 |
Oklahoma Medical Research Foundation |
Method for selecting recombinase variants with altered specificity
|
AU4210700A
(en)
*
|
1999-04-09 |
2000-11-14 |
Iconix Pharmaceuticals, Inc. |
Methods and nucleic acid vectors for rapid and parallel assay development, for characterization of the activities of biological response modifiers
|
WO2000075353A1
(en)
*
|
1999-06-02 |
2000-12-14 |
Trustees Of The University Of Pennsylvania |
Compositions and methods useful for production of recombinant viruses which require helper viruses
|
US7039700B2
(en)
*
|
2001-04-04 |
2006-05-02 |
Chatguard.Com |
System and method for monitoring and analyzing communications
|
DE10131786A1
(de)
*
|
2001-07-04 |
2003-01-16 |
Sungene Gmbh & Co Kgaa |
Rekombinationssysteme und Verfahren zum Entfernen von Nukleinsäuresequenzen aus dem Genom eukaryotischer Organismen
|
ATE375388T1
(de)
*
|
2001-07-27 |
2007-10-15 |
Us Gov Health & Human Serv |
Systeme zur stellengerichteten in-vivo-mutagenese mit oligonukleotiden
|
DE60236182D1
(de)
|
2001-09-14 |
2010-06-10 |
Cellectis |
Zufällige integration von polynukleotide nach in vivo linearisierung
|
US20030148352A1
(en)
*
|
2001-12-14 |
2003-08-07 |
Yale University |
Intracellular generation of single-stranded DNA
|
WO2003054189A2
(de)
*
|
2001-12-20 |
2003-07-03 |
Sungene Gmbh & Co. Kgaa |
Verfahren zur transformation von pflanzlichen plastiden
|
US6989265B2
(en)
|
2002-01-23 |
2006-01-24 |
Wisconsin Alumni Research Foundation |
Bacteria with reduced genome
|
US8119365B2
(en)
|
2002-01-23 |
2012-02-21 |
Wisconsin Alumni Research Foundation |
Insertion sequence-free bacteria
|
US8765408B2
(en)
|
2002-01-23 |
2014-07-01 |
Wisconsin Alumni Research Foundation |
Prophage element-free bacteria
|
US8039243B2
(en)
|
2002-01-23 |
2011-10-18 |
Wisconsin Alumni Research Foundation |
Insertion sequence-free bacteria
|
US20100151556A1
(en)
*
|
2002-03-15 |
2010-06-17 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
WO2009095742A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
JP2005520519A
(ja)
*
|
2002-03-15 |
2005-07-14 |
セレクティス |
ハイブリッドおよび単鎖メガヌクレアーゼならびにその使用
|
JP3943048B2
(ja)
|
2002-04-29 |
2007-07-11 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組織の細胞dnaからの組込みウイルスの直接レスキュー及び増幅の方法
|
DE50310378D1
(de)
|
2002-07-26 |
2008-10-02 |
Basf Plant Science Gmbh |
Neue selektionsverfahren
|
US7303906B2
(en)
|
2002-09-06 |
2007-12-04 |
Wisconsin Alumni Research Foundation |
Competent bacteria
|
US20060206949A1
(en)
|
2003-01-28 |
2006-09-14 |
Sylvain Arnould |
Custom-made meganuclease and use thereof
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
PT2025756E
(pt)
*
|
2003-11-18 |
2011-09-28 |
Bayer Bioscience Nv |
Inserção direccionada de adn em plantas
|
US8133558B2
(en)
*
|
2004-08-30 |
2012-03-13 |
Plastics Suppliers, Inc. |
Polylactic acid blown film and method of manufacturing same
|
EP1669456A3
(de)
|
2004-12-11 |
2006-07-12 |
SunGene GmbH |
Expressionskasseten für meristembevorzugte Expression in Pflanzen
|
WO2006074956A1
(en)
*
|
2005-01-14 |
2006-07-20 |
Bayer Bioscience N.V. |
Improved plant transformation methods
|
US20110158974A1
(en)
|
2005-03-15 |
2011-06-30 |
Cellectis |
Heterodimeric Meganucleases and Use Thereof
|
AU2006232828B2
(en)
|
2005-04-04 |
2011-01-27 |
Bayer Cropscience Nv. |
Methods and means for removal of a selected DNA sequence
|
WO2006133983A1
(en)
|
2005-04-19 |
2006-12-21 |
Basf Plant Science Gmbh |
Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants
|
EP1890862A4
(de)
*
|
2005-04-19 |
2008-09-03 |
Plastic Suppliers Inc |
Schrumpffolien aus polymilchsäure und herstellungsverfahren dafür
|
WO2009134714A2
(en)
*
|
2008-04-28 |
2009-11-05 |
Precision Biosciences, Inc. |
Fusion molecules of rationally-designed dna-binding proteins and effector domains
|
US8021867B2
(en)
|
2005-10-18 |
2011-09-20 |
Duke University |
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
|
WO2007060495A1
(en)
*
|
2005-10-25 |
2007-05-31 |
Cellectis |
I-crei homing endonuclease variants having novel cleavage specificity and use thereof
|
DK1954571T3
(en)
*
|
2005-11-21 |
2019-04-23 |
Plastic Suppliers Inc |
Polylactic acid shrink film and molding methods
|
EP2316954B1
(de)
|
2006-05-18 |
2013-10-30 |
Biogemma |
Verfahren zum Ausführen der homologen Rekombination in Pflanzen
|
US20080015164A1
(en)
*
|
2006-05-19 |
2008-01-17 |
Sangamo Biosciences, Inc. |
Methods and compositions for inactivation of dihydrofolate reductase
|
WO2007139982A2
(en)
|
2006-05-25 |
2007-12-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene inactivation
|
PL2049663T3
(pl)
|
2006-08-11 |
2015-08-31 |
Dow Agrosciences Llc |
Homologiczna rekombinacja za pośrednictwem nukleazy z palcami cynkowymi
|
CA2664414C
(en)
|
2006-09-28 |
2016-07-12 |
Bayer Bioscience N.V. |
Methods and means for removal of a selected dna sequence
|
EP2074219B1
(de)
|
2007-02-16 |
2013-11-20 |
BASF Plant Science GmbH |
Nukleinsäuresequenzen zur regulierung embryospezifischer expression in einkeimblättrigen pflanzen
|
US8765448B2
(en)
|
2007-06-05 |
2014-07-01 |
Bayer CropScience, N.V. |
Methods and means for exact replacement of target DNA in eukaryotic organisms
|
EP2167666A2
(de)
|
2007-06-29 |
2010-03-31 |
Pioneer Hi-Bred International Inc. |
Verfahren zur veränderung des genoms einer monokotyledonen-zelle
|
KR101510778B1
(ko)
|
2007-07-12 |
2015-04-10 |
상가모 바이오사이언스 인코포레이티드 |
알파 1,6 당전이효소(fut8) 유전자 발현을 비활성화시키기 위한 방법 및 조성물
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
EP2205749B1
(de)
|
2007-09-27 |
2016-05-18 |
Dow AgroSciences LLC |
Technisch konstruierte zinkfingerproteine mit genen für 5-enolpyruvylshikimat-3-phosphat-synthase als ziel
|
EP2597155B1
(de)
|
2007-10-25 |
2016-11-23 |
Sangamo BioSciences, Inc. |
Verfahren und Zusammensetzungen für gezielte Integration
|
EP2215252A4
(de)
*
|
2007-12-07 |
2011-01-26 |
Prec Biosciences Inc |
Rational entworfene meganukleasen mit erkennungssequenzen aus dnase-hypersensitiven regionen des menschlichen genoms
|
WO2009114321A2
(en)
*
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
EP2105505A1
(de)
|
2008-03-28 |
2009-09-30 |
Celonic AG |
Verfahren und Materialien zur wiederholbaren Erzeugung hochproduktiver Zelllinien für rekombinante Proteine
|
EP2281050B1
(de)
|
2008-04-14 |
2014-04-02 |
Sangamo BioSciences, Inc. |
Lineare donorkonstrukte zur gezielten integration
|
US8791324B2
(en)
*
|
2008-04-21 |
2014-07-29 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
EP3090778B1
(de)
|
2008-05-30 |
2018-12-05 |
Stryker Corporation |
Verfahren zum zusammenbauen von implantierbaren elektrodenanordnungen mit einer gekrümmten form
|
KR101802393B1
(ko)
|
2008-06-10 |
2017-11-28 |
상가모 테라퓨틱스, 인코포레이티드 |
Bax- 및 bak-결함 세포주들의 제조 방법 및 조성물
|
AU2009271011B2
(en)
*
|
2008-07-14 |
2015-10-22 |
Precision Biosciences, Inc. |
Recognition sequences for I-Crei-derived meganucleases and uses thereof
|
CN102159722B
(zh)
|
2008-08-22 |
2014-09-03 |
桑格摩生物科学股份有限公司 |
用于靶向单链切割和靶向整合的方法和组合物
|
AU2009311697B2
(en)
*
|
2008-10-29 |
2014-12-18 |
Sangamo Therapeutics, Inc. |
Methods and compositions for inactivating glutamine synthetase gene expression
|
KR101803737B1
(ko)
|
2008-12-04 |
2017-12-01 |
상가모 테라퓨틱스, 인코포레이티드 |
징크 핑거 뉴클레아제를 이용한 랫트의 유전체 편집
|
AR074783A1
(es)
|
2008-12-17 |
2011-02-09 |
Dow Agrosciences Llc |
Metodos y composiciones para expresar uno o mas productos de un acido nucleico exogeno integrado al locus zp15 de una celula vegetal
|
CA2934285C
(en)
|
2009-02-04 |
2018-11-27 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating neuropathies
|
CA2755192C
(en)
|
2009-03-20 |
2018-09-11 |
Sangamo Biosciences, Inc. |
Modification of cxcr4 using engineered zinc finger proteins
|
CA2756833C
(en)
*
|
2009-04-09 |
2019-11-19 |
Sangamo Biosciences, Inc. |
Targeted integration into stem cells
|
US8772008B2
(en)
*
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
AU2010266705B2
(en)
|
2009-06-30 |
2014-06-05 |
Sangamo Therapeutics, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
CA2766123A1
(en)
|
2009-07-08 |
2011-01-13 |
Cellular Dynamics International, Inc. |
Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene
|
US9234016B2
(en)
|
2009-07-28 |
2016-01-12 |
Sangamo Biosciences, Inc. |
Engineered zinc finger proteins for treating trinucleotide repeat disorders
|
WO2011019385A1
(en)
|
2009-08-11 |
2011-02-17 |
Sangamo Biosciences, Inc. |
Organisms homozygous for targeted modification
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
MY174390A
(en)
|
2009-10-22 |
2020-04-15 |
Sangamo Biosciences Inc |
Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
|
AU2010325549B2
(en)
*
|
2009-11-27 |
2017-04-20 |
Basf Plant Science Company Gmbh |
Optimized endonucleases and uses thereof
|
EP2529017A2
(de)
|
2009-12-30 |
2012-12-05 |
Pioneer Hi-Bred International, Inc. |
Verfahren und zusammensetzungen für gezielte polynukleotidmodifikation
|
US9255259B2
(en)
|
2010-02-09 |
2016-02-09 |
Sangamo Biosciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
JP2013526844A
(ja)
|
2010-03-22 |
2013-06-27 |
フィリップ・モーリス・プロダクツ・ソシエテ・アノニム |
植物の酵素活性の改変
|
WO2011139349A1
(en)
|
2010-05-03 |
2011-11-10 |
Sangamo Biosciences, Inc. |
Compositions for linking zinc finger modules
|
EP2571512B1
(de)
|
2010-05-17 |
2017-08-23 |
Sangamo BioSciences, Inc. |
Neue dna-bindende proteine und verwendungen davon
|
BR112012031323A2
(pt)
|
2010-06-09 |
2015-09-08 |
Bayer Cropscience Nv |
métodos e meios para modificação de genoma vegetal em uma sequência de nucleotídeos comumente usada na engenahria genética de plantas
|
US9593317B2
(en)
|
2010-06-09 |
2017-03-14 |
Bayer Cropscience Nv |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
WO2012004671A2
(en)
|
2010-07-07 |
2012-01-12 |
Cellectis |
Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
|
WO2012010976A2
(en)
|
2010-07-15 |
2012-01-26 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the tert gene and uses thereof
|
AU2011281062B2
(en)
|
2010-07-21 |
2015-01-22 |
Board Of Regents, The University Of Texas System |
Methods and compositions for modification of a HLA locus
|
JP2013537410A
(ja)
|
2010-07-23 |
2013-10-03 |
シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー |
標的化エンドヌクレアーゼおよび一本鎖核酸を用いたゲノム編集
|
US9187762B2
(en)
|
2010-08-13 |
2015-11-17 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (HPPD) activity
|
WO2012047598A1
(en)
|
2010-09-27 |
2012-04-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for inhibiting viral entry into cells
|
AR085302A1
(es)
|
2011-02-24 |
2013-09-18 |
Sanofi Sa |
Metodo de produccion de anticuerpos sialilados
|
EA201391373A1
(ru)
|
2011-03-23 |
2014-07-30 |
Пайонир Хай-Бред Интернэшнл, Инк. |
Способы получения сложного локуса трансгенных признаков
|
CN103597082B
(zh)
|
2011-06-06 |
2017-09-15 |
拜尔作物科学公司 |
用于在预选位点修饰植物基因组的方法和手段
|
EP2748323B1
(de)
|
2011-08-22 |
2019-05-01 |
BASF Agricultural Solutions Seed US LLC |
Verfahren und vorrichtung zur modifizierung eines pflanzengenoms
|
CN103917644A
(zh)
|
2011-09-21 |
2014-07-09 |
桑格摩生物科学股份有限公司 |
调控转基因表达的方法和组合物
|
EP2771457B1
(de)
|
2011-10-27 |
2017-11-22 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur veränderung des hprt-locus
|
US20130180005A1
(en)
|
2012-01-06 |
2013-07-11 |
Pioneer Hi Bred International Inc |
Method to Screen Plants for Genetic Elements Inducing Parthenogenesis in Plants
|
JP6490426B2
(ja)
|
2012-02-29 |
2019-03-27 |
サンガモ セラピューティクス, インコーポレイテッド |
ハンチントン病を治療するための方法および組成物
|
MX369788B
(es)
|
2012-05-02 |
2019-11-21 |
Dow Agrosciences Llc |
Modificacion dirigida de deshidrogenasa de malato.
|
RU2650819C2
(ru)
|
2012-05-07 |
2018-04-17 |
Сангамо Терапьютикс, Инк. |
Способы и композиции для опосредованной нуклеазой направленной интеграции трансгенов
|
CA2878037C
(en)
|
2012-07-11 |
2021-08-31 |
Sangamo Biosciences, Inc. |
Methods and compositions for delivery of biologics
|
HUE041553T2
(hu)
|
2012-07-11 |
2019-05-28 |
Sangamo Therapeutics Inc |
Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
|
EP2687605A1
(de)
|
2012-07-19 |
2014-01-22 |
Biogemma |
Verfahren zur Durchführung einer homologen Rekombination
|
ES2812599T3
(es)
|
2012-08-29 |
2021-03-17 |
Sangamo Therapeutics Inc |
Procedimientos y composiciones para el tratamiento de una afección genética
|
ES2824024T3
(es)
|
2012-10-10 |
2021-05-11 |
Sangamo Therapeutics Inc |
Compuestos modificadores de células T y usos de los mismos
|
US20150291967A1
(en)
|
2012-10-31 |
2015-10-15 |
Luc Mathis |
Coupling herbicide resistance with targeted insertion of transgenes in plants
|
EP2925779A1
(de)
|
2012-11-30 |
2015-10-07 |
Institut Pasteur |
Verwendung von anti-fcyri- und/oder anti-fcyriia-antikörpern zur behandlung von arthritis, entzündungen, thrombozytopenie und allergischem schock
|
KR20150096696A
(ko)
|
2012-12-13 |
2015-08-25 |
다우 아그로사이언시즈 엘엘씨 |
메이즈에서 특정 유전자좌로의 정밀 유전자 표적화
|
WO2014138379A1
(en)
*
|
2013-03-06 |
2014-09-12 |
The Johns Hopkins University |
The telomerator-a tool for chromosome engineering
|
EP2971039B1
(de)
|
2013-03-14 |
2020-01-01 |
Immusoft Corporation |
Verfahren zur in-vitro-speicher-b-zellen-differenzierung und -transduktion mit vsv-g-pseudotypisierten viralen vektoren
|
CN105263312A
(zh)
|
2013-04-05 |
2016-01-20 |
美国陶氏益农公司 |
用于在植物基因组内整合外源序列的方法和组合物
|
CA3109801C
(en)
|
2013-08-22 |
2024-01-09 |
Andrew Cigan |
Plant genome modification using guide rna/cas endonuclease systems and methods of use
|
CA2920899C
(en)
|
2013-08-28 |
2023-02-28 |
Sangamo Biosciences, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
WO2015057976A1
(en)
|
2013-10-17 |
2015-04-23 |
Sangamo Biosciences, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
|
CN105899665B
(zh)
|
2013-10-17 |
2019-10-22 |
桑格摩生物科学股份有限公司 |
用于核酸酶介导的基因组工程改造的递送方法和组合物
|
AU2014341929B2
(en)
|
2013-11-04 |
2017-11-30 |
Corteva Agriscience Llc |
Optimal maize loci
|
UA120503C2
(uk)
|
2013-11-04 |
2019-12-26 |
Дау Агросайєнсиз Елелсі |
Спосіб одержання трансгенної клітини рослини кукурудзи
|
UY35816A
(es)
|
2013-11-04 |
2015-05-29 |
Dow Agrosciences Llc |
?locus óptimos de la soja?.
|
BR112016010175A2
(pt)
|
2013-11-11 |
2017-10-03 |
Sangamo Biosciences Inc |
Repressor genético, seus usos, e composição farmacêutica
|
EP3960856A1
(de)
|
2013-11-13 |
2022-03-02 |
Children's Medical Center Corporation |
Nukleasevermittelte regulierung der genexpression
|
EP3757116A1
(de)
|
2013-12-09 |
2020-12-30 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen für genom-engineering
|
PL3102673T3
(pl)
|
2014-02-03 |
2020-11-02 |
Sangamo Therapeutics, Inc. |
Sposoby i kompozycje do leczenia talasemii beta
|
EP3102702B1
(de)
|
2014-02-05 |
2019-04-03 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Fehlerfreie dna-sequenzierung
|
TW201538518A
(zh)
|
2014-02-28 |
2015-10-16 |
Dow Agrosciences Llc |
藉由嵌合基因調控元件所賦予之根部特異性表現
|
US9624498B2
(en)
|
2014-03-18 |
2017-04-18 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
MX2016014565A
(es)
|
2014-05-08 |
2017-05-23 |
Sangamo Biosciences Inc |
Metodos y composiciones para tratar la enfermedad de huntington.
|
US9944933B2
(en)
*
|
2014-07-17 |
2018-04-17 |
Georgia Tech Research Corporation |
Aptamer-guided gene targeting
|
US9616090B2
(en)
|
2014-07-30 |
2017-04-11 |
Sangamo Biosciences, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
ES2886012T3
(es)
|
2014-09-16 |
2021-12-16 |
Sangamo Therapeutics Inc |
Métodos y composiciones para la ingeniería y corrección de genomas mediadas por nucleasas en células madre hematopoyéticas
|
KR20170081268A
(ko)
|
2014-11-27 |
2017-07-11 |
단지거 이노베이션즈 엘티디. |
게놈 편집용 핵산 구조체
|
CA2971517A1
(en)
|
2014-12-19 |
2016-06-23 |
Universite De Nantes |
Anti il-34 antibodies
|
EP3247366A4
(de)
|
2015-01-21 |
2018-10-31 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur identifizierung hochspezifischer nukleasen
|
ES2959608T3
(es)
|
2015-04-03 |
2024-02-27 |
Dana Farber Cancer Inst Inc |
Composición y métodos de edición del genoma de células B
|
JP2018511331A
(ja)
|
2015-04-15 |
2018-04-26 |
ダウ アグロサイエンシィズ エルエルシー |
導入遺伝子発現のための植物プロモーター
|
MX2017012936A
(es)
|
2015-04-15 |
2018-02-01 |
Dow Agrosciences Llc |
Promotor de plantas para la expresion transgenica.
|
US11827904B2
(en)
|
2015-04-29 |
2023-11-28 |
Fred Hutchinson Cancer Center |
Modified stem cells and uses thereof
|
EP3091076A1
(de)
|
2015-05-07 |
2016-11-09 |
Limagrain Europe |
Für die haploide induktion in maispflanzen verantwortliches polynukleotid und zugehörige verfahren
|
AU2016291778B2
(en)
|
2015-07-13 |
2021-05-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
TW201718862A
(zh)
|
2015-09-22 |
2017-06-01 |
Dow Agrosciences Llc |
用於轉殖基因表現之植物啟動子及3’utr
|
TW201718861A
(zh)
|
2015-09-22 |
2017-06-01 |
道禮責任有限公司 |
用於轉殖基因表現之植物啟動子及3’utr
|
CA3002151A1
(en)
|
2015-10-22 |
2017-04-27 |
Dow Agrosciences Llc |
Plant promoter for transgene expression
|
US20170121726A1
(en)
|
2015-11-04 |
2017-05-04 |
Dow Agrosciences Llc |
Plant promoter for transgene expression
|
AU2016369490C1
(en)
|
2015-12-18 |
2021-12-23 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the T cell receptor
|
CN108699132B
(zh)
|
2015-12-18 |
2023-08-11 |
桑格摩生物治疗股份有限公司 |
Mhc细胞受体的靶向破坏
|
CN109069568B
(zh)
|
2016-02-02 |
2023-07-07 |
桑格摩生物治疗股份有限公司 |
用于连接dna结合结构域和切割结构域的组合物
|
CN109476706A
(zh)
|
2016-02-16 |
2019-03-15 |
耶鲁大学 |
用于促进靶向基因编辑的组合物及其使用方法
|
CN109069870B
(zh)
|
2016-02-24 |
2022-04-29 |
洛克菲勒大学 |
基于胚胎细胞的用于亨廷顿氏病的治疗候选物筛选系统、模型及它们的应用
|
EP3427055A1
(de)
|
2016-03-07 |
2019-01-16 |
Pierre Fabre Medicament |
Neues universelles verfahren zur aufnahme und analyse von adcs zur charakterisierung der wirkstoffverteilung und des wirkstoff-antikörper-verhältnisses bei biologischen proben
|
US11021713B2
(en)
|
2016-05-25 |
2021-06-01 |
Cargill, Incorporated |
Engineered nucleases to generate deletion mutants in plants
|
US20190247436A1
(en)
|
2016-07-21 |
2019-08-15 |
Maxcyte, Inc. |
Methods and compositions for modifying genomic dna
|
AU2017315414B2
(en)
|
2016-08-24 |
2024-02-15 |
Sangamo Therapeutics, Inc. |
Engineered target specific nucleases
|
EA201990591A1
(ru)
|
2016-09-23 |
2019-08-30 |
Фред Хатчинсон Кэнсер Рисерч Сентер |
Tcr, специфичные к минорному антигену гистосовместимости (h) ha-1, и их применения
|
CN110291199B
(zh)
|
2016-10-03 |
2023-12-22 |
美国陶氏益农公司 |
用于转基因表达的植物启动子
|
EP3518657B1
(de)
|
2016-10-03 |
2022-07-13 |
Corteva Agriscience LLC |
Pflanzenpromoter zur transgenen expression
|
CA3039673A1
(en)
|
2016-10-20 |
2018-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of fabry disease
|
US11020492B2
(en)
|
2016-10-31 |
2021-06-01 |
Sangamo Therapeutics, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
JP7416406B2
(ja)
|
2016-12-08 |
2024-01-17 |
ケース ウェスタン リザーブ ユニバーシティ |
機能的ミエリン産生を増進させるための方法および組成物
|
CN106834332B
(zh)
*
|
2017-03-09 |
2021-05-04 |
中国科学院过程工程研究所 |
一种重组质粒及其制备方法和应用
|
BR112019018863A8
(pt)
|
2017-03-15 |
2023-05-02 |
Hutchinson Fred Cancer Res |
Tcrs de alta afinidade específicos para mage-a1 e usos dos mesmos
|
CA3061612A1
(en)
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
AU2018261366A1
(en)
|
2017-05-03 |
2019-10-31 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CTFR) gene
|
US10780119B2
(en)
|
2017-05-24 |
2020-09-22 |
Effector Therapeutics Inc. |
Methods and compositions for cellular immunotherapy
|
US20210106618A1
(en)
|
2017-09-06 |
2021-04-15 |
Fred Hutchinson Cancer Research Center |
Methods for improving adoptive cell therapy
|
CA3071661A1
(en)
|
2017-09-06 |
2019-03-14 |
Fred Hutchinson Cancer Research Center |
Strep-tag specific chimeric receptors and uses thereof
|
WO2019079777A1
(en)
|
2017-10-20 |
2019-04-25 |
Fred Hutchinson Cancer Research Center |
COMPOSITIONS AND METHODS FOR TIGIT AND / OR CD112R TARGETING IMMUNOTHERAPY OR COMPRISING THE OVEREXPRESSION OF CD226
|
US11661611B2
(en)
|
2017-11-09 |
2023-05-30 |
Sangamo Therapeutics, Inc. |
Genetic modification of cytokine inducible SH2-containing protein (CISH) gene
|
WO2019109047A1
(en)
|
2017-12-01 |
2019-06-06 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for 5t4 and uses thereof
|
DK3720879T3
(da)
|
2017-12-05 |
2022-06-20 |
Progastrine Et Cancers S A R L |
Kombinationsterapi mellem anti-progastrin-antistof og immunterapi til behandling af cancer
|
WO2019140278A1
(en)
|
2018-01-11 |
2019-07-18 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting core binding factor antigens
|
AU2019224051A1
(en)
|
2018-02-26 |
2020-09-03 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
EP3759492A1
(de)
|
2018-02-27 |
2021-01-06 |
ECS-Progastrin SA |
Progastrin als biomarker für immuntherapie
|
EP3765601A1
(de)
|
2018-03-16 |
2021-01-20 |
Immusoft Corporation |
Genetisch manipulierte b-zellen zur sezernierung von follistatin und verfahren zur verwendung davon zur behandlung von follistatinbedingten krankheiten, leiden, störungen und zur erhöhung des muskelwachstums und der muskelkraft
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
AU2019306165A1
(en)
|
2018-07-20 |
2021-02-25 |
Pierre Fabre Medicament |
Receptor for vista
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
MX2021001938A
(es)
|
2018-08-22 |
2021-04-19 |
Fred Hutchinson Cancer Center |
Inmunoterapia dirigida a antigenos kras o her2.
|
WO2020047099A1
(en)
|
2018-08-28 |
2020-03-05 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for adoptive t cell therapy incorporating induced notch signaling
|
CN113015741A
(zh)
|
2018-09-18 |
2021-06-22 |
桑格摩生物治疗股份有限公司 |
程序性细胞死亡1(pd1)特异性核酸酶
|
WO2020068702A1
(en)
|
2018-09-24 |
2020-04-02 |
Fred Hutchinson Cancer Research Center |
Chimeric receptor proteins and uses thereof
|
BR112021005665A2
(pt)
|
2018-09-28 |
2021-06-22 |
Pierre Fabre Medicament |
novas imunocitocinas para o tratamento de câncer
|
JP2022506781A
(ja)
|
2018-11-09 |
2022-01-17 |
フレッド ハッチンソン キャンサー リサーチ センター |
メソテリンを標的とする免疫療法
|
AU2020204657A1
(en)
|
2019-01-04 |
2021-07-29 |
Pioneer Hi-Bred International, Inc. |
Engineered nucleases to generate mutations in plants
|
US11453639B2
(en)
|
2019-01-11 |
2022-09-27 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
EP3826664A4
(de)
|
2019-02-06 |
2022-10-26 |
Sangamo Therapeutics, Inc. |
Verfahren zur behandlung von mukopolysaccharidose typ i
|
CA3130618A1
(en)
|
2019-02-20 |
2020-08-27 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for ras neoantigens and uses thereof
|
CA3132845A1
(en)
|
2019-03-11 |
2020-09-17 |
Fred Hutchinson Cancer Research Center |
High avidity wt1 t cell receptors and uses thereof
|
EP3946384A1
(de)
|
2019-04-02 |
2022-02-09 |
Sangamo Therapeutics, Inc. |
Verfahren zur behandlung von beta-thalassämie
|
EP3958871A1
(de)
|
2019-04-23 |
2022-03-02 |
Sangamo Therapeutics, Inc. |
Modulatoren der chromosom-9-open-reading-frame-72-genexpression und ihre verwendungen
|
WO2021022223A1
(en)
|
2019-08-01 |
2021-02-04 |
Sana Biotechnology, Inc. |
Dux4 expressing cells and uses thereof
|
EP4017872A1
(de)
|
2019-08-20 |
2022-06-29 |
Fred Hutchinson Cancer Center |
Wt-1-spezifische t-zell-immuntherapie
|
AU2020336302A1
(en)
|
2019-08-23 |
2022-03-03 |
Sana Biotechnology, Inc. |
CD24 expressing cells and uses thereof
|
EP4025606A1
(de)
|
2019-09-04 |
2022-07-13 |
Y-Biologics Inc. |
Anti-vsig4-antikörper oder antigenbindendes fragment und verwendungen davon
|
KR20220071248A
(ko)
|
2019-10-02 |
2022-05-31 |
상가모 테라퓨틱스, 인코포레이티드 |
알파-시누클레인 발현을 억제시키기 위한 아연 핑거 단백질 전사 인자
|
WO2021067864A1
(en)
|
2019-10-02 |
2021-04-08 |
Sangamo Therapeutics, Inc. |
Zinc finger protein transcription factors for treatment of prion disease
|
WO2021116277A1
(en)
|
2019-12-10 |
2021-06-17 |
Institut Pasteur |
New antibody blocking human fcgriiia and fcgriiib
|
US20230293593A1
(en)
|
2020-03-25 |
2023-09-21 |
Sana Biotechnology, Inc. |
Hypoimmunogenic neural cells for the treatment of neurological disorders and conditions
|
EP3889183A1
(de)
|
2020-04-01 |
2021-10-06 |
Pierre Fabre Medicament |
Proteinkomplex mit einem immunzytokin
|
JP2023525510A
(ja)
|
2020-05-06 |
2023-06-16 |
セレクティス ソシエテ アノニム |
治療用タンパク質の送達のために細胞を遺伝子改変する方法
|
JP2023525513A
(ja)
|
2020-05-06 |
2023-06-16 |
セレクティス ソシエテ アノニム |
細胞ゲノムにおける外因性配列の標的化挿入のための方法
|
US20230190871A1
(en)
|
2020-05-20 |
2023-06-22 |
Sana Biotechnology, Inc. |
Methods and compositions for treatment of viral infections
|
JP2023535365A
(ja)
|
2020-07-16 |
2023-08-17 |
アクイタス セラピューティクス インコーポレイテッド |
脂質ナノ粒子に使用するためのカチオン性脂質
|
KR20230074718A
(ko)
|
2020-08-13 |
2023-05-31 |
사나 바이오테크놀로지, 인크. |
저면역원성 세포로 감작된 환자를 치료하는 방법 및 관련 방법 및 조성물
|
WO2022046760A2
(en)
|
2020-08-25 |
2022-03-03 |
Kite Pharma, Inc. |
T cells with improved functionality
|
WO2022066973A1
(en)
|
2020-09-24 |
2022-03-31 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting pbk or oip5 antigens
|
CN116724053A
(zh)
|
2020-09-24 |
2023-09-08 |
弗雷德哈钦森癌症中心 |
靶向sox2抗原的免疫治疗
|
AU2021350099A1
(en)
|
2020-09-25 |
2023-04-27 |
Sangamo Therapeutics, Inc. |
Zinc finger fusion proteins for nucleobase editing
|
TW202222841A
(zh)
|
2020-10-06 |
2022-06-16 |
福瑞德哈金森腫瘤研究中心 |
用於治療表現mage-a1之疾病的組成物及方法
|
WO2022104109A1
(en)
|
2020-11-13 |
2022-05-19 |
Catamaran Bio, Inc. |
Genetically modified natural killer cells and methods of use thereof
|
US20220162288A1
(en)
|
2020-11-25 |
2022-05-26 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
CA3201767A1
(en)
|
2020-12-14 |
2022-06-23 |
Thomas M. Schmitt |
Compositions and methods for cellular immunotherapy
|
CA3200509A1
(en)
|
2020-12-31 |
2022-07-07 |
Sonja SCHREPFER |
Methods and compositions for modulating car-t activity
|
EP4301786A1
(de)
|
2021-03-03 |
2024-01-10 |
Pierre Fabre Medicament |
Anti-vsig4-antikörper oder antigenbindendes fragment und verwendungen davon
|
EP4172212A1
(de)
|
2021-04-30 |
2023-05-03 |
Pierre Fabre Medicament |
Neuer stabiler anti-vista-antikörper
|
CN115867645A
(zh)
|
2021-05-18 |
2023-03-28 |
赛斯尔擎生物技术(上海)有限公司 |
修饰细胞的方法
|
AU2022283291A1
(en)
|
2021-05-27 |
2023-11-02 |
Sana Biotechnology, Inc. |
Hypoimmunogenic cells comprising engineered hla-e or hla-g
|
WO2023287827A2
(en)
|
2021-07-14 |
2023-01-19 |
Sana Biotechnology, Inc. |
Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
|
WO2023288281A2
(en)
|
2021-07-15 |
2023-01-19 |
Fred Hutchinson Cancer Center |
Chimeric polypeptides
|
IL310550A
(en)
|
2021-08-04 |
2024-03-01 |
Univ Colorado Regents |
LAT-activating chimeric antigen receptor T cells and methods of using them
|
WO2023019229A1
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified primary cells for allogeneic cell therapy
|
CA3227613A1
(en)
|
2021-08-11 |
2023-02-16 |
William Dowdle |
Inducible systems for altering gene expression in hypoimmunogenic cells
|
AU2022325955A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
WO2023019227A1
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
WO2023019226A1
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
CA3232212A1
(en)
|
2021-10-01 |
2023-04-06 |
Ping XIANG |
Transgenic rodents for cell line identification and enrichment
|
WO2023069790A1
(en)
|
2021-10-22 |
2023-04-27 |
Sana Biotechnology, Inc. |
Methods of engineering allogeneic t cells with a transgene in a tcr locus and associated compositions and methods
|
WO2023122337A1
(en)
|
2021-12-23 |
2023-06-29 |
Sana Biotechnology, Inc. |
Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods
|
WO2023154578A1
(en)
|
2022-02-14 |
2023-08-17 |
Sana Biotechnology, Inc. |
Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
|
WO2023158836A1
(en)
|
2022-02-17 |
2023-08-24 |
Sana Biotechnology, Inc. |
Engineered cd47 proteins and uses thereof
|
WO2023173123A1
(en)
|
2022-03-11 |
2023-09-14 |
Sana Biotechnology, Inc. |
Genetically modified cells and compositions and uses thereof
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
WO2023213814A1
(en)
|
2022-05-02 |
2023-11-09 |
Pierre Fabre Medicament |
New formulation of anti vista antibody
|
EP4360451A1
(de)
|
2022-10-25 |
2024-05-01 |
Limagrain Europe |
Mutanten zur haploiden induktion
|